Hbk Sorce Advisory LLC Athenex, Inc. Transaction History

Hbk Sorce Advisory LLC

  • $2.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$0.12 - $0.21 $1,580 - $2,765
13,170 Added 83.78%
28,890 $4,000
Q1 2022

May 13, 2022
BUY
$0.79 - $1.59 $1,580 - $3,180
2,000 Added 14.58%
15,720 $13,000
Q4 2021

Feb 15, 2022
BUY
$1.36 - $2.94 $3,060 - $6,615
2,250 Added 19.62%
13,720 $19,000
Q3 2021

Nov 15, 2021
BUY
$2.97 - $4.84 $34,065 - $55,514
11,470 New
11,470 $35,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email